A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Malaysian Journal of Fundamental and Applied Sciences
Metal stents used in the treatment of percutaneous coronary intervention (PCI) have revolutionized in treating atherosclerosis disease. Starting from the emergence of bare metal stent (BMS), this stent has been progressively developed into drug-eluting stent (DES) and biodegradable stent. By focusing on DES, various drugs have been used to coat metal stent with the aims to overcome in-stent restenosis and stent thrombosis. Even though, both problems are covered successfully by DES, however, DESdoi:10.11113/mjfas.v15n2.1115 fatcat:wogsmovcbfgrnh4rhtj3n26hua